For consumers, the Singa karaoke app gives access to a huge library of high-quality karaoke songs on the mobile, web browser, and Smart TV. You can sing on your own, make it a party with friends, or find the nearest Singa-powered karaoke venue and hit the stage. On the B2B side of things, Singa helps pubs, bars, and other nightlife venues grow their revenues with professional karaoke software. Singa has a rapidly growing network of over 1000 venues in Europe, Australia, and the USA.
Aves Netsec is a cybersecurity company. The company protects information assets of companies from unsolicited visitors. Its solution adds a new layer of security to the network which negates attacker from the ability to function. Capturing attackers and drawing intelligence from them with the Aves solution enables enterprises to understand attacker motives, build risk profiles and quantify attack impacts and subsequently improve their security posture. Aves Netsec the company was founded by Simo Kohonen in 2014 and is headquartered in London, England.
Plate IQ is accounts payable automation software designed for restaurants. It saves time, increases data accuracy, and provides insight into spend by extracting line item data from invoices and automatically coding purchases to GL accounts. Plate IQ integrates with top accounting and inventory software, virtually eliminating data entry from the AP process.
Mezmo, formerly LogDNA, is an observability platform to manage and take action on your data. It ingests, processes, and routes log data to fuel enterprise-level application development and delivery, security, and compliance use cases.
Developing self-driving software, proprietary simulation tools and neural network acceleration hardware IP, AImotive is building an ecosystem to aid the deployment of automated driving. To catalyse industry collaboration our products are scalable, modular and hardware agnostic. We build on our team’s expertise in artificial intelligence, sensor fusion, 3D graphics and real-world automated driving workloads, to support partners in realizing their self-driving goals.
Siklu Wireless Communications delivers carrier-grade milimetric-wave Ethernet radio solutions scalable to Gigabit capacities with paradigm-shifting price performance.
Developing self-driving software, proprietary simulation tools and neural network acceleration hardware IP, AImotive is building an ecosystem to aid the deployment of automated driving. To catalyse industry collaboration our products are scalable, modular and hardware agnostic. We build on our team’s expertise in artificial intelligence, sensor fusion, 3D graphics and real-world automated driving workloads, to support partners in realizing their self-driving goals.
Answerbook automates and personalizes email marketing for eCommerce. Answerbook's predictive intelligence engine analyzes consumer behavior on email, website and purchase history. With this information, Answerbook automatically sends relevant follow up emails to consumers.
N-Trig is a startup that develops touch screens and pen styluses. With an extensive patent portfolio, N-trig also supports a variety of applications for different market segments including consumer, education, business, healthcare, graphic and industrial design, gaming, entertainment, and multimedia. Founded in 1999, N-trig is a global operation, maintaining its: R&D facility, corporate headquarters, and management in Kfar Saba, Israel; sales, OEM, and ISV support in Austin, Texas and San Jose, California; ODM, operations, and supply chain support in Taipei, Taiwan, Tokyo, Japan and Shanghai, China.
N-Trig is a startup that develops touch screens and pen styluses. With an extensive patent portfolio, N-trig also supports a variety of applications for different market segments including consumer, education, business, healthcare, graphic and industrial design, gaming, entertainment, and multimedia. Founded in 1999, N-trig is a global operation, maintaining its: R&D facility, corporate headquarters, and management in Kfar Saba, Israel; sales, OEM, and ISV support in Austin, Texas and San Jose, California; ODM, operations, and supply chain support in Taipei, Taiwan, Tokyo, Japan and Shanghai, China.
N-Trig is a startup that develops touch screens and pen styluses. With an extensive patent portfolio, N-trig also supports a variety of applications for different market segments including consumer, education, business, healthcare, graphic and industrial design, gaming, entertainment, and multimedia. Founded in 1999, N-trig is a global operation, maintaining its: R&D facility, corporate headquarters, and management in Kfar Saba, Israel; sales, OEM, and ISV support in Austin, Texas and San Jose, California; ODM, operations, and supply chain support in Taipei, Taiwan, Tokyo, Japan and Shanghai, China.
Panaya, a SaaS-based company certified by SAP, Oracle, and Salesforce.com, offers an all-in-one platform for Smart Testing solutions and Change Intelligence tailored for ERP, CRM, and cloud business applications. Panaya accelerates and de-risks digital landscapes with AI-powered Test Automation, Test Management, and Impact Analysis. Panaya's focus on ease of use and an intuitive interface ensures seamless collaboration between business and IT, empowering business users and IT professionals to gain real-time visibility and control over their projects. This capability enables faster releases and continuous delivery of high-quality software. Since its founding in 2006, over 3,000 companies across 62 countries, including a third of the Fortune 500, have trusted Panaya to drive rapid, quality testing and change management in their enterprise business applications
Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins through its ProCellEx® plant cell-based protein expression system. Using ProCellEx, Protalix is focused on the development and commercialization of a proprietary pipeline of novel and biosimilar proteins that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action. Protalix’s initial commercial focus is on complex therapeutic proteins for the treatment of genetic disorders, such as Gaucher disease and Fabry disease. Protalix is also advancing additional recombinant biopharmaceutical drug development programs, including a TNF inhibitor for inflammatory diseases. Protalix’s pipeline is led by ELELYSO™(taliglucerase alfa for injection), which received approval from the U.S. Food and Drug Administration on May 1, 2012. ELELYSO is the first FDA-approved plant cell-based recombinant therapeutic protein. Protalix has partnered with Pfizer for worldwide development and commercialization of ELELYSO, excluding Israel, where Protalix has retained full rights. Marketing applications for taliglucerase alfa have been submitted for Europe, Israel, Brazil and Australia, with additional regulatory submissions in progress.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.